EYPT icon

EyePoint Pharmaceuticals

138 hedge funds and large institutions have $476M invested in EyePoint Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-13
Holders Change %
-8.61%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
49
Reduced
47
Closed
34
Calls
$5.09M
Puts
$2.57M
Net Calls
+$2.52M
Net Calls Change
+$7.78M
Name Holding Trade Value Shares
Change
Shares
Change %
ACM
151
Aquatic Capital Management
Illinois
-$194K -22,300 Closed
AIM
152
Aigen Investment Management
New York
-$172K -19,800 Closed
LP
153
LMR Partners
United Kingdom
-$172K -19,785 Closed
ET
154
Entropy Technologies
New York
-$153K -17,560 Closed
OPS
155
Orion Portfolio Solutions
Nebraska
-$146K -16,787 Closed
BCI
156
Brinker Capital Investments
Pennsylvania
-$146K -16,787 Closed
SO
157
STRS Ohio
Ohio
-$144K -16,600 Closed
AGM
158
Alpine Global Management
New York
-$117K -13,471 Closed
Stifel Financial
159
Stifel Financial
Missouri
-$116K -13,388 Closed
PD
160
Point72 (DIFC)
United Arab Emirates
-$34.5K -3,962 Closed
PA
161
Parallel Advisors
California
-$12.1K -1,395 Closed
FHA
162
First Horizon Advisors
Tennessee
-$3.2K -368 Closed
CA
163
Clearstead Advisors
Ohio
-$2.05K -235 Closed
ATPW
164
Ashton Thomas Private Wealth
Arizona
-$1.31K -151 Closed
QL
165
Quarry LP
New York
-$1.21K -139 Closed
WTC
166
WhitTier Trust Company
Nevada
-$356 -41 Closed
IC
167
Innealta Capital
Texas
-$313 -36 Closed
PS
168
Principal Securities
Iowa
-$209 -24 Closed
PPC
169
Park Place Capital
Alabama
-$200 -23 Closed
CA
170
Continuum Advisory
Idaho
-$139 -16 Closed